WALTHAM, Mass. – University of New Mexico Hospital will use Glytec’s eGlycemic Management System to help reduce hypoglycemia in patients with diabetes.
“With the Centers for Medicare & Medicaid poised to institute a new quality measure for severe hypoglycemia, I would say our decision to implement Glytec’s eGlycemic Management System is very timely,” said Dr. Kendall Rogers, division chief of hospital medicine at University of New Mexico Hospital, in a statement. “We believe that using Glytec’s eGlycemic Management System will not only help elevate our performance, but will make it far easier for our physicians and nurses to effectively care for hospitalized patients with diabetes.”
The eGlycemic Management System centers on decision support for personalized insulin dosing and has been designed in accordance with standards of care sanctioned by the American Diabetes Association, American Association of Clinical Endocrinologists, Society of Hospital Medicine and Society of Critical Care Medicine.
The technology will be integrated with University of New Mexico Hospital’s electronic medical record and deployed across the institution for both critically ill and non-critically patients.
In addition to the eGMS technology suite, Glytec will provide University of New Mexico Hospital with a comprehensive array of expert professional services and methodologies tailored to workflows and configured for safe and effective management of intravenous and basal bolus insulin, as well as the transition from IV to subcutaneous insulin.
“We look forward to improving our transition management and further standardizing our nursing practices with a system that makes it easy to do the right thing and gives us the data and reports we need to continually improve our care,” said Dr. Matthew Bouchonville, medical director of Endo ECHO at University of New Mexico Hospital, in a statement.